CT3001

· Crossignal Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CT3001, covering 2024-11-04 to 2024-11-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Determine the Effect of CT3001 in Patients with Advanced Solid Tumors [Phase 1, Phase 2]